	Despesas De Vendas E Administração		Data
AbbVie	USD 3.89B	325M	2025-12
Agios Pharmaceuticals	USD 42.97M	1.7M	2025-12
Alnylam Pharmaceuticals	USD 285.06M	22.47M	2025-12
Amgen	USD 1.94B	237M	2025-12
Arrowhead Research	USD 46.02M	8.84M	2025-12
Astellas Pharma	JPY 221.78B	14.94B	2025-12
AstraZeneca	USD 4.61B	4.46B	2025-12
Bayer	EUR 3.4B	140M	2025-09
Biogen	USD 545.2M	38.6M	2025-09
BioMarin Pharmaceutical	USD 223.42M	8.86M	2025-09
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Daiichi Sankyo	JPY 228.23B	39.15B	2025-12
Eli Lilly	USD 3.13B	391.3M	2025-12
Exelixis	USD 123.02M	19.9M	2025-12
Gilead Sciences	USD 1.78B	425M	2025-12
GlaxoSmithKline	GBP 2.68B	518M	2025-12
Incyte	USD 390.41M	61.33M	2025-12
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
Merck	USD 2.85B	215M	2025-12
Moderna	USD 308M	40M	2025-12
Nektar Therapeutics	USD -0.18	0.07	2024-09
Novartis	USD 3.31B	134M	2025-09
Novartis	USD 3.3B	137M	2025-09
Pfizer	USD 4.08B	894M	2025-12
Puma Biotechnology	USD 16.82M	8.15M	2024-09
Regeneron Pharmaceuticals	USD 775M	117.2M	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
Vertex Pharmaceuticals	USD 487M	41.9M	2025-12

Agios Pharmaceuticals Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.